213 related articles for article (PubMed ID: 16507322)
1. Dramatic decrease in the pulmonary artery systolic pressure and disappearance of the interatrial shunt with sildenafil treatment in a patient with primary pulmonary hypertension with atrial septal aneurysm and a severe right to left shunt through the patent foramen ovale.
Karakaya O; Ozdemir N; Kaymaz C; Barutcu I
Int J Cardiol; 2006 Jun; 110(1):97-9. PubMed ID: 16507322
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial.
Ghofrani HA; Reichenberger F; Kohstall MG; Mrosek EH; Seeger T; Olschewski H; Seeger W; Grimminger F
Ann Intern Med; 2004 Aug; 141(3):169-77. PubMed ID: 15289213
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil in the treatment of pulmonary hypertension.
Barnett CF; Machado RF
Vasc Health Risk Manag; 2006; 2(4):411-22. PubMed ID: 17323595
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil for enhanced performance at high altitude?
Rubin LJ; Naeije R
Ann Intern Med; 2004 Aug; 141(3):233-5. PubMed ID: 15289224
[No Abstract] [Full Text] [Related]
5. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence.
Raja SG; Danton MD; MacArthur KJ; Pollock JC
J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):722-35. PubMed ID: 17023298
[No Abstract] [Full Text] [Related]
6. Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy.
Chaudhari M; Vogel M; Wright C; Smith J; Haworth SG
Arch Dis Child Fetal Neonatal Ed; 2005 Nov; 90(6):F527-8. PubMed ID: 16244212
[TBL] [Abstract][Full Text] [Related]
7. Summaries for patients. Sildenafil increases exercise capacity in low-oxygen settings.
Ann Intern Med; 2004 Aug; 141(3):I12. PubMed ID: 15289233
[No Abstract] [Full Text] [Related]
8. Sildenafil for pulmonary hypertension in ARDS: a new pleasant effect?
Blanch L; Albaiceta GM
Intensive Care Med; 2010 May; 36(5):729-31. PubMed ID: 20130829
[No Abstract] [Full Text] [Related]
9. Sildenafil citrate for the treatment of pulmonary hypertension.
Hrometz SL; Shields KM
Drugs Today (Barc); 2006 Dec; 42(12):771-84. PubMed ID: 17285150
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension.
Sebkhi A; Strange JW; Phillips SC; Wharton J; Wilkins MR
Circulation; 2003 Jul; 107(25):3230-5. PubMed ID: 12796132
[TBL] [Abstract][Full Text] [Related]
11. Observational trials in pulmonary arterial hypertension: low scientific evidence but high clinical value.
Hoeper MM
Eur Respir J; 2007 Mar; 29(3):432-4. PubMed ID: 17329488
[No Abstract] [Full Text] [Related]
12. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
Humbert M
Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
[No Abstract] [Full Text] [Related]
13. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN
Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.
Bharani A; Mathew V; Sahu A; Lunia B
Indian Heart J; 2003; 55(1):55-9. PubMed ID: 12760589
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
16. Sildenafil for primary and secondary pulmonary hypertension.
Watanabe H; Ohashi K; Takeuchi K; Yamashita K; Yokoyama T; Tran QK; Satoh H; Terada H; Ohashi H; Hayashi H
Clin Pharmacol Ther; 2002 May; 71(5):398-402. PubMed ID: 12011826
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic approaches to pulmonary hypertension in hemoglobinopathies: Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathy.
Derchi G; Forni GL
Ann N Y Acad Sci; 2005; 1054():471-5. PubMed ID: 16339700
[TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease.
Zeng WJ; Lu XL; Xiong CM; Shan GL; Liu ZH; Ni XH; Gu Q; Zhao ZH; Li JJ; He JG;
Clin Cardiol; 2011 Aug; 34(8):513-8. PubMed ID: 21678455
[TBL] [Abstract][Full Text] [Related]
20. Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension.
Baliga RS; Zhao L; Madhani M; Lopez-Torondel B; Visintin C; Selwood D; Wilkins MR; MacAllister RJ; Hobbs AJ
Am J Respir Crit Care Med; 2008 Oct; 178(8):861-9. PubMed ID: 18689467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
